Isosilychristin
Isosilychristin is a P-glycoprotein inhibitor with an IC50 of 25.9 μM. Isosilychristin downregulates the expression of transmembrane efflux pumps, exerts intracellular antioxidant effects, and inhibits NO production in macrophages. Isosilychristin regulates cell cycle progression, and exerts weak antiproliferative and colony formation inhibitory effects in prostate cancer cells. Isosilychristin reduces bacterial intercellular communication and reverses the drug resistance of Staphylococcus aureus. Isosilychristin can be used in studies related to prostate cancer, inflammation and bacterial infections.
For research use only. We do not sell to patients.
- CAS No.: 77182-66-2
- Formula: C25H22O10
- Molecular Weight:482.44
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Huh-7 | IC50 |
130 μM
Compound: 11
|
Cytotoxicity against human Huh7.5.1 cells after 72 hrs
Cytotoxicity against human Huh7.5.1 cells after 72 hrs
|
[PMID: 23673225] |
In Vitro
Isosilychristin acts as an oxygen radical scavenger in cell-free ORAC assays with an IC50 of 6.0 μM; it scavenges free radicals in HepG2 cells with an IC50 of 13 μM; and it inhibits LPS-induced NO production in RAW 264.7 macrophages with an IC50 of 59.8 μM[1].
Isosilychristin inhibits P-gp activity in isolated membranes with an IC50 of 25.9 μM, and completely abolishes P-gp-mediated ATP consumption at concentrations of 225 μM and above[1].
Isosilychristin (10-30 μM; 72 h co-incubation with Doxorubicin (HY-15142A)) exhibits only mild toxicity to HOC and HOC/ADR cells when used alone, and only weakly sensitizes HOC/ADR cells to doxorubicin at a concentration of 20 μM[1].
Isosilychristin (10 μM; 48 h) downregulates ABCB1 gene expression by 20% in HOC/ADR human ovarian cancer cells, while altering the expression of several other ABC transporter genes[1].
Isosilychristin (90 μM; 10 days) exerts only a slight inhibitory effect on colony formation of human prostate cancer PC3 cells (inhibition rate: 19.9%)[2].
Isosilychristin (60-90 μM; 72 h) causes a slight but statistically significant change in cell cycle distribution at 60 μM in human prostate cancer PC3 cells, and induces a mild, concentration-dependent G1-phase cell cycle arrest in human androgen-dependent prostate cancer LNCaP cells[2].
Isosilychristin reverses the Oxacillin (HY-B0925A) resistance of multidrug-resistant Staphylococcus aureus NEM 449 at a concentration of 30 μM; it potently inhibits AI-2-mediated quorum sensing in Vibrio campbellii ATCC BAA-1119 with an EC50 of 14.7 μM, and shows no toxicity to this bacterium even at concentrations as high as 200 μM[3].
Isosilychristin shows no toxicity to human skin fibroblasts, human renal tubular epithelial cells and human embryonic kidney cells, with the highest tested concentration reaching 200 μM[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:doxorubicin-resistant (HOC/ADR) human ovarian carcinoma cells
-
Concentration:10 μM
-
Incubation Time:48 h
-
Result:Downregulated the expression of the ABCB1 (P-gp) gene by 20% in HOC/ADR cells.
Downregulated ABCA2, ABCB9, ABCC10, and ABCF1 genes.
Upregulated ABCD1, ABCD4, ABCE1, ABCF2, and ABCG4 genes.
Did not affect the expression of the ABCC2 (BCRP) gene.
-
Cell Line:human prostate carcinoma PC3 cells
-
Concentration:90 μM
-
Incubation Time:10 days (treated every 48 h)
-
Result:Inhibited PC3 cell colony formation by 19.9%.
-
Cell Line:human prostate carcinoma PC3 cells, human androgen-dependent prostate carcinoma LNCaP cells
-
Concentration:60, 90 μM
-
Incubation Time:72 h
-
Result:Elevated PC3 G2/M population to 17.45% and decreased G1 population to 51.77% with unmodified S phase at 60 μM over 72 h, while 90 μM brought no cell cycle variation to PC3 cells.
Elevated LNCaP G1 population and reduced S population without G2/M fluctuation under both concentrations; G1 reached 70.23% and S dropped to 19.91% at 60 μM, and G1 rose to 71.81% with S declining to 18.48% at 90 μM.
-
Cell Line:human prostate carcinoma PC3 cells
-
Concentration:90 μM
-
Incubation Time:72 h
-
Result:Did not cause significant changes in the expression levels of cyclins (D1, D3, E, A, B1), CDKs (2, 4, Cdc2), CDKIs (p21, p27), Skp2, phosphorylated Chk2 (Thr68), total Chk2, or Cdc25 phosphatases (A, B, C) relative to control.
Chemical Information
-
CAS No. 77182-66-2
-
Molecular Weight 482.44
-
Formula C25H22O10
-
SMILES
OC[C@@H]1C2=C([C@H]3OC4=CC(O)=CC(O)=C4C([C@@H]3O)=O)C=CC(O)=C2O[C@H]1C5=CC(OC)=C(C=C5)O
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Flow cytometric DNA-content cell-cycle staining
Flow cytometric DNA-content cell-cycle staining measures the fluorescence intensity of DNA-bound fluorochromes in single cells or nuclei to estimate DNA content distributions, allowing assignment of populations to G0/G1, S, and G2/M phases by DNA histogram deconvolution. Propidium iodide (PI) intercalates into DNA, and PI fluorescence is proportional to cellular DNA content when staining is performed under conditions that make DNA accessible and minimize non-DNA signal. Cells with G2/M DNA content are expected to show approximately twice the fluorescence intensity of G0/G1 cells, while S-phase cells occupy intermediate fluorescence values. PI-based DNA-content analysis can also detect cells with fractional DNA content, often reported as sub-G1, when DNA fragmentation and extraction during staining reduce retained DNA signal in apoptotic cells. DAPI is an alternative DNA fluorochrome for univariate DNA-content analysis, while bivariate approaches combining DNA content with proliferation
-
BrdU Incorporation Assay
Bromodeoxyuridine (BrdU) incorporation assay is based on the principle that BrdU, a thymidine analog, is incorporated into newly synthesized DNA during the S phase of the cell cycle, thereby serving as a marker of DNA replication and cellular proliferation. Incorporated BrdU can be detected using anti-BrdU antibodies following DNA denaturation, enabling visualization or quantification of proliferating cells through immunochemical detection methods such as immunofluorescence or immunohistochemistry.
-
Protocol for Cell Cycle
Cell-cycle analysis by flow cytometry measures DNA content in single cells to estimate the fraction of cells in G0/G1, S, and G2/M phases. Propidium iodide intercalates into DNA, and after RNA removal with RNase, fluorescence intensity reflects cellular DNA content: 2N cells are assigned to G0/G1, cells between 2N and 4N to S phase, and 4N cells to G2/M. DNA-content analysis alone cannot reliably separate G0 from G1 or G2 from M. Ki-67 can distinguish quiescent G0 cells from cycling cells, EdU or BrdU incorporation marks active DNA synthesis in S phase, and phospho-histone H3 staining identifies mitotic cells within the 4N population.
-
Soft Agar Colony Formation Assay
Soft agar colony formation assay measures anchorage-independent growth, in which transformed or tumorigenic cells proliferate as colonies in a semisolid agar matrix while many non-transformed adherent cells fail to proliferate without attachment; classic studies showed that growth in semisolid medium correlates with tumorigenicity in nude mice, and later protocol papers describe the method as a stringent in vitro assay for malignant transformation. The readout is the number, size, morphology, or signal intensity of colonies formed within agar after incubation; published formats include manual colony counting after staining, 96-well or 384-well quantitative formats, DNA-binding dye detection, MTT/tetrazolium-based detection, digital image analysis, and PCR-based marker detection from soft agar cultures.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Colony Formation (Clonogenic) Assay
The clonogenic (colony formation) assay measures the ability of a single cell to retain reproductive viability and form a macroscopic colony, typically defined as a cluster derived from one progenitor cell after a defined growth period. This assay is widely used to evaluate cell survival after exposure to ionizing radiation or cytotoxic treatments and is considered a standard method in radiation biology for generating dose-response relationships of reproductive cell death. Colony formation reflects long-term proliferative capacity rather than short-term metabolic activity, and survival is quantified by comparing treated versus untreated conditions based on colony number and derived survival fractions.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
[1]. Viktorová J, et al. Antioxidant, Anti-Inflammatory, and Multidrug Resistance Modulation Activity of Silychristin Derivatives. Antioxidants (Basel, Switzerland). 2019 Aug 14;8(8):303. [Content Brief]
[2]. Deep G, et al. Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells. International journal of cancer. 2008 Jul 01;123(1):41-50. [Content Brief]
[3]. Holasová K, et al. Flavonolignans from silymarin modulate antibiotic resistance and virulence in Staphylococcus aureus. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2022 May;149:112806. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)